We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+24.55%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$8.79B
AUM Growth
+$1.45B
Cap. Flow
-$72.5M
Cap. Flow %
-0.82%
Top 10 Hldgs %
20.48%
Holding
2,420
New
180
Increased
1,163
Reduced
213
Closed
125

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$8.64M
2
WORK
Slack Technologies, Inc.
WORK
+$7.6M
3
ABBV icon
AbbVie
ABBV
+$7.02M
4
TMUS icon
T-Mobile US
TMUS
+$6.46M
5
OTIS icon
Otis Worldwide
OTIS
+$5.52M

Sector Composition

Rank Sector Weight
1 Technology 21.58%
2 Healthcare 14.02%
3 Financials 12.88%
4 Consumer Discretionary 10.4%
5 Industrials 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQIX icon
101
Equinix
EQIX
$105B
$16.3M 0.18%
23,151
+1,169
+5% +$791K
GS icon
102
Goldman Sachs
GS
$301B
$16M 0.18%
80,945
-1,198
-1% -$225K
AMD icon
103
Advanced Micro Devices
AMD
$795B
$16M 0.18%
303,739
+2,244
+0.7% +$119K
TJX icon
104
TJX Companies
TJX
$169B
$15.8M 0.18%
313,289
+709
+0.2% +$35.6K
GE icon
105
GE Aerospace
GE
$379B
$15.6M 0.18%
458,995
+7,325
+2% +$247K
TGT icon
106
Target
TGT
$69.7B
$15.6M 0.18%
129,675
-943
-0.7% -$108K
TMUS icon
107
T-Mobile US
TMUS
$189B
$15.5M 0.18%
149,036
+67,438
+83% +$6.46M
DUK icon
108
Duke Energy
DUK
$96.4B
$15.4M 0.17%
192,191
+4,274
+2% +$361K
ATVI
109
DELISTED
Activision Blizzard
ATVI
$15.3M 0.17%
201,510
+3,482
+2% +$243K
CME icon
110
CME Group
CME
$94.4B
$15.2M 0.17%
93,783
+1,411
+2% +$253K
SYK icon
111
Stryker
SYK
$133B
$15.2M 0.17%
84,308
+1,312
+2% +$242K
MS icon
112
Morgan Stanley
MS
$342B
$15.1M 0.17%
313,190
+12,994
+4% +$546K
MU icon
113
Micron Technology
MU
$1.05T
$15M 0.17%
290,878
+5,522
+2% +$260K
CB icon
114
Chubb
CB
$133B
$14.9M 0.17%
118,047
+1,229
+1% +$142K
AMAT icon
115
Applied Materials
AMAT
$437B
$14.4M 0.16%
237,681
-428
-0.2% -$23.1K
FISV
116
Fiserv Inc
FISV
$27.2B
$14.4M 0.16%
147,079
-132
-0.1% -$13.3K
MRSH
117
Marsh
MRSH
$90.2B
$14.3M 0.16%
133,442
+3,358
+3% +$340K
SO icon
118
Southern Company
SO
$106B
$14.3M 0.16%
276,171
+5,847
+2% +$325K
ILMN icon
119
Illumina
ILMN
$28.9B
$14.2M 0.16%
39,524
+572
+1% +$184K
CSX icon
120
CSX Corp
CSX
$92.6B
$14M 0.16%
600,591
-747
-0.1% -$16.5K
APD icon
121
Air Products & Chemicals
APD
$68.1B
$13.8M 0.16%
57,277
+457
+0.8% +$104K
ADSK icon
122
Autodesk
ADSK
$52.2B
$13.6M 0.15%
56,847
+131
+0.2% +$25.8K
HUM icon
123
Humana
HUM
$46.2B
$13.4M 0.15%
34,577
+442
+1% +$165K
GPN icon
124
Global Payments
GPN
$22.7B
$13.3M 0.15%
78,228
+758
+1% +$126K
TFC icon
125
Truist Financial
TFC
$64.3B
$13.2M 0.15%
352,412
+6,736
+2% +$243K

Similar funds

MetLife Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, MetLife Investment Management held 2,420 positions worth $8.79B, up 20% from $7.34B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

MetLife Investment Management's Q2 2020 filing shows 180 new, 1,163 increased, 213 reduced and 125 closed positions. Its largest new stake was DexCom: 96,564 shares worth $9.79M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $143M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

  • MetLife Investment Management's largest Q2 2020 buy was DexCom: 96,564 shares worth $9.79M.
  • MetLife Investment Management added most to AbbVie in Q2 2020, an estimated $7.02M increase.
  • MetLife Investment Management's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $143M.
  • MetLife Investment Management fully exited Allergan plc in Q2 2020, selling an estimated $15M.
  • MetLife Investment Management's ten largest holdings make up 20% of its $8.79B portfolio in Q2 2020.
  • MetLife Investment Management opened 180 new positions and closed 125 in Q2 2020.
  • MetLife Investment Management's portfolio value rose 20% quarter-over-quarter to $8.79B.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.